<?xml version="1.0" encoding="UTF-8" standalone="yes"?><?xml-stylesheet type="text/xsl" href="/oai-pmh-repository/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2026-10-15T09:44:58Z</responseDate>
    <request verb="GetRecord" identifier="oai:data.mendeley.com/kch397zzpt.1" metadataPrefix="oai_dc">https://data.mendeley.com/oai</request>
    <GetRecord>
        <record>
            <header>
                <identifier>oai:data.mendeley.com/kch397zzpt.1</identifier>
                <datestamp>2019-01-17T22:55:58Z</datestamp>
            </header>
            <metadata><oai_dc:dc xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <dc:creator>Yang, Zhenjun</dc:creator>
    <dc:title>Data for: Structural optimization and additional targets identification of antisense oligonucleotide G3139 encapsulated in a neutral cytidinyl-lipid combined with a cationic lipid in vitro and in vivo</dc:title>
    <dc:publisher>Mendeley Data</dc:publisher>
    <dc:description>Antisense oligonucleotides (ASOs) usually contain a fully phosphorothioate (PS) backbone, which possibly interacts with many genes and proteins under intracellular conditions. G3139 is an ASO that targets Bcl-2 mRNA and induces cell apoptosis. Here, we report a kind of cytidinyl-lipid combined with a cationic lipid (DNCA/CLD, molar ration, 28:3, named mix), which might interact with oligonucleotides via H-bond formation, pi-stacking and electrostatic interaction, accompanied by low zeta potentials. The IC50 value of G3139 delivered by mix-lipid reduced from above 20 uM to 0.158 uM for MCF-7/ADR, and exhibited stronger antiproliferation upon other cancer cell lines. In addition, PS modification in the 3&apos;-half of G3139 (especial at positions 13-16) enhanced serum stability, target specificity and anticancer activity. Also, a locked nucleic acid (LNA) gapmer G3139 (LNA-G3139) showed superior antiproliferation (78.5%) and Bcl-2 mRNA suppression effects (85.5%) at 200 nM, mainly due to its high mRNA affinity. More apoptosis-associated targets were identified, and a lower level of non-specific protein binding (HSA) determined revealed that both antisense and aptamer mechanisms might simultaneously exist. A combination of a new delivery system and chemical modifications, such as in LNA-G3139, may have potential clinical application prospects in the future.</dc:description>
    <dc:subject>Oblimersen</dc:subject>
    <dc:subject>Antisense</dc:subject>
    <dc:contributor>Ma, Yuan</dc:contributor>
    <dc:type>Dataset</dc:type>
    <dc:identifier>doi:10.17632/kch397zzpt.1</dc:identifier>
    <dc:identifier>oai:data.mendeley.com/kch397zzpt.1</dc:identifier>
    <dc:rights>Public Domain Dedication</dc:rights>
    <dc:rights>http://creativecommons.org/publicdomain/zero/1.0/</dc:rights>
    <dc:relation>https://data.mendeley.com/datasets/kch397zzpt</dc:relation>
    <dc:date>2019-01-17T22:55:58Z</dc:date>
    <dc:date>2019-05-06T00:00:00Z</dc:date>
</oai_dc:dc></metadata>
        </record>
    </GetRecord>
</OAI-PMH>
